Aztiq and Innobic Announce Pricing of Secondary Sale of globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
BERNAMA - AZTIQ, INNOBIC ANNOUNCE SECONDARY SALE PRICING OF LOTUS COMMON STOCK bernama.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bernama.com Daily Mail and Mail on Sunday newspapers.
The Consortium jointly, through Aztiq II HoldCo, has completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo Róbert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo. The Consortium's collective.
Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.